TriunityCX | ARC Platform
Introducing the ARC Platform

Where Hospital Outcomes
Meet Pharma Intelligence

ARC is a pharma-funded care coordination platform that reduces hospital readmissions, drives medication adherence, and generates real-world evidence at no cost to health systems.

ARC Platform
๐ŸฅHealth Systems
๐Ÿ’ŠPharma Partners
๐Ÿ“ŠReal-World Evidence
๐ŸคCare Teams
~20% of Medicare patients readmitted within 30 days, costing hospitals millions in CMS penalties annually
$0 net cost to hospitals. ARC is fully funded by pharmaceutical partnerships
Real-Time market intelligence delivered to pharma partners as patients move through the care continuum
The Platform

Adherence & Readmission Care

ARC is a real-world evidence system built on a simple but powerful insight: hospitals need care coordination infrastructure they cannot afford to build alone, and pharma companies need patient outcome data they cannot get anywhere else.


ARC bridges that gap, connecting health systems with pharmaceutical funding to deploy coordinated discharge and adherence programs that benefit patients, providers, and partners simultaneously.


Request a Demo
A
AdherenceStructured post-discharge follow-up and medication adherence programs that keep patients on therapy and out of the ED.
R
ReadmissionTargeted interventions for high-risk patients that reduce 30-day readmissions and protect hospitals from CMS penalties.
C
CareA coordinated care model powered by real-world data, creating a continuous feedback loop between patient outcomes and pharma intelligence.
How It Works

A model built around your evidence needs

You subscribe to the ARC platform, define your target health systems and therapeutic areas, and TriunityCX manages all deployment and coordination. You receive clean, de-identified outcome data with no operational burden on your team.

01
Subscribe to the ARC Platform
Your organization subscribes to ARC and defines the health systems and therapeutic areas where you need real-world evidence. TriunityCX handles all deployment and coordination on the ground.
02
ARC Deploys Inside Target Health Systems
TriunityCX deploys ARC's care coordination program inside your target health systems at no cost to the hospital. Patients receive structured follow-up after discharge and your brand is present throughout the care continuum.
03
Real-World Evidence Delivered to Your Team
As patients move through care coordination, de-identified outcome data on adherence, therapy persistence, and readmission rates is delivered directly to your research and commercial teams within 30 days of enrollment.
What You Get

Clinical, behavioral, and financial data
in a single platform

ARC delivers the metrics your medical affairs, commercial, and market access teams need. Captured prospectively at the point of care, not reconstructed from claims months after the fact.

Medical Affairs
Real-world outcome data for publications, scientific congress presentations, and label discussions with FDA.
Commercial
Prescription fill rate and persistence data to identify where intent at discharge breaks down before patients actually take the drug.
Market Access
Site-specific cost avoidance and readmission data to build a credible economic argument in payer negotiations.
HEOR
Prospective, discharge-anchored outcome data for economic models that support pricing and reimbursement decisions.
Patient Services
Patient-reported behavioral data showing exactly where copay assistance and support programs are not reaching the patients who need them.
ARC Platform โ€” Evidence Dashboard
LIVE DATA De-identified ยท HIPAA Compliant
Therapeutic Area: Cardiovascular Oncology Diabetes All Q1 2025 ยท 14 Health Systems
Patients Enrolled
2,847
โ†‘ 9% vs last quarter
Adherence Rate
61.3%
โ†‘ 8.1pts vs baseline
30-Day Readmission
16.8%
โ†“ 4.6pts vs control
90-Day Persistence
54.7%
Active cohort
Prescription Fill Rate
58.2%
โ†‘ 9.3pts vs control
Monthly Prescription Fill Rate โ€” ARC Enrolled vs. Control
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ARC Enrolled Control Group
90-Day Adherence by Health System
Hospital A
65%
Hospital B
61%
Hospital C
58%
Hospital D
54%
Primary Reason for Non-Adherence
Captured during live post-discharge calls by care coordinators, not patient surveys
Cost concerns (38%)
Side effects (24%)
Felt better, stopped (20%)
Forgot / no reminder (18%)
Financial Impact
Avg. Cost Avoidance Per Enrolled Patient $1,840
Est. Readmission Cost Avoided (Q1) $2.1M
Payer Mix โ€” Commercial 44%
Payer Mix โ€” Medicare 38%
All data de-identified per HIPAA Safe Harbor. Sample figures shown for illustrative purposes.
Sample Evidence Report

This is what your team receives

Delivered quarterly. De-identified. Segmented by therapeutic area and health system.

ARC Evidence Report โ€” Cardiovascular

Q1 2025 ยท 14 Health Systems ยท De-identified ยท Confidential

SAMPLE
2,847
Patients Enrolled
61.3%
Medication Adherence Rate
16.8%
30-Day Readmission Rate
54.7%
90-Day Therapy Persistence
58.2%
Prescription Fill Rate
Prescription Fill Rate โ€” ARC vs. Control
ARC Enrolled Control Group
Primary Reason for Non-Adherence
Live post-discharge calls by care coordinators, not surveys
Cost concerns (38%)
Side effects (24%)
Felt better, stopped (20%)
Forgot / no reminder (18%)
$1,840
Avg. Cost Avoidance Per Enrolled Patient
$2.1M
Est. Readmission Cost Avoided (Q1)
44% / 38%
Payer Mix โ€” Commercial / Medicare
Key Finding: Cost concerns were the primary driver of early discontinuation in this cohort at 38%. ARC-enrolled patients showed an 8.1 point improvement in 90-day adherence versus the control group. Readmission rates fell from 21.4% in the control cohort to 16.8% among ARC-enrolled patients. This data was available within 30 days of patient enrollment, not six months after claims were processed.
Generated by TriunityCX ARC Platform ยท De-identified per HIPAA Safe Harbor ยท Sample data shown for illustrative purposes triunitycx.com

Your medical affairs, commercial, HEOR, and market access teams are currently getting this data late, incomplete, or not at all. ARC delivers it within 30 days, tied to a specific discharge event, with behavioral context that no claims database can provide.

Want to see what this looks like for your therapeutic area and target health systems?

Request a Demo
For Health Systems

Cut Readmissions.
Meet CMS Requirements.
At Zero Cost.

ARC gives hospitals the care coordination infrastructure to reduce 30-day readmissions, support CMS ACCESS Model compliance, and improve patient outcomes, all funded entirely through pharmaceutical partnerships.

  • Reduce costly 30-day readmissions across high-risk DRGs
  • Support CMS ACCESS Model compliance requirements
  • No implementation cost, pharma funding covers the program
  • Structured discharge follow-up and adherence outreach
  • Outcomes reporting embedded in existing workflows
  • Scalable from single department to system-wide deployment
For Pharma Partners

Real-World Evidence.
At the Point of Care.

ARC gives pharmaceutical companies direct access to de-identified, real-world patient outcome data, generated at the point of care, in the populations that matter most to your pipeline.

  • Real-time, de-identified patient outcome data by therapy area
  • Market intelligence on adherence patterns and gaps
  • Branded presence within hospital care coordination workflows
  • Support for post-market surveillance and RWE commitments
  • Scalable data across multiple health system partners
  • Turnkey program, TriunityCX manages all hospital relationships
Regulatory Alignment

Built for the CMS ACCESS Model

The CMS ACCESS Model is putting new pressure on hospitals to demonstrate care coordination across the discharge continuum. ARC is purpose-built to help health systems meet these requirements while generating the data infrastructure needed for long-term compliance.


Rather than building expensive internal programs, hospitals can leverage ARC's pharma-funded model to demonstrate the coordinated care, adherence tracking, and outcomes reporting the ACCESS Model demands.


See ARC in Action
๐Ÿ“‹

Care Coordination

Structured discharge planning and follow-up workflows aligned to CMS ACCESS requirements.

๐Ÿ’Š

Medication Adherence

Post-discharge adherence outreach and monitoring across high-risk patient populations.

๐Ÿ“Š

Outcomes Reporting

Automated outcomes data and reporting infrastructure for compliance documentation.

๐Ÿ”’

Data Governance

HIPAA-compliant data architecture with de-identification protocols for all partner reporting.

See What ARC Can Do for Your Pipeline

Schedule a conversation about your therapeutic area, your evidence gaps, and how ARC can generate the data your team needs from the point of care.

Request a Demo